1.Henry NL, Hayes DF. Cancer biomarkers. Molecular Oncology. 2012;6(2):140–6.
National Cancer Institute.. NCI Dictionary of Cancer Terms. NCI Dictionary of Cancer Terms. USA: National Cancer Institute; 2014. Available from: http://www.cancer.gov/dictionary.
Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med. 2010;134(6):907–22.
Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Archives of Pathology & Laboratory Medicine. 2014;138(2):241–56.
College of American Pathologists.. Cancer Protocol Templates. 2014. Available from: http://www.cap.org.
Bartley AN, Hamilton SR. Select biomarkers for tumors of the gastrointestinal tract: present and future. Arch Pathol Lab Med. 2015;139(4):457–68.
Bernicker E. Biomarker testing in non-small cell lung cancer: a clinician's perspective. Arch Pathol Lab Med. 2015;139(4):448–50.
Chastain EC, Duncavage EJ. Clinical Prognostic Biomarkers in Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma. Archives of Pathology & Laboratory Medicine. 2015;139(5):602–7. 10. Cagle PT, Olsen RJ, Portier BP, Takei H, Bernard DW. A new everevolving paradigm. Arch Pathol Lab Med. 2015;139(4):446–7.
Yu PP, Hoffman MA, Hayes DF. Biomarkers and oncology: the path forward to a learning health system. Arch Pathol Lab Med. 2015;139(4):451–6.
Sholl LM. Biomarkers in lung adenocarcinoma: a decade of progress. Arch Pathol Lab Med. 2015;139(4):469–80.
Cagle PT, Stein K, Oommen J, Shemon M, Kyle W. Cancer biomarker testing in the everyday practice of pathology. Arch Pathol Lab Med. 2015;139(5):583–4.
Simpson RW, Berman MA, Foulis PR, Divaris DX, Birdsong GG, Mirza J, et al. Cancer biomarkers: the role of structured data reporting. Arch Pathol Lab Med. 2015;139(5):587–93.